Literature DB >> 16646083

A20 inhibits oxidized low-density lipoprotein-induced apoptosis through negative Fas/Fas ligand-dependent activation of caspase-8 and mitochondrial pathways in murine RAW264.7 macrophages.

Hong-Liang Li1, Ai-Bing Wang, Ran Zhang, Yu-Sheng Wei, Hou-Zao Chen, Zhi-Gang She, Yue Huang, De-Pei Liu, Chih-Chuan Liang.   

Abstract

A20 was originally characterized as a TNF-inducible gene in human umbilical vein endothelial cells. As an NF-kappaB target gene, A20 is also induced in many other cell types by a wide range of stimuli. Expression of A20 has been shown to protect from TNF-induced apoptosis and also functions via a negative-feedback loop to block NF-kappaB activation induced by TNF and other stimuli. To date, there are no reports on whether A20 can protect OxLDL-induced apoptosis in macrophages. For the first time we report that A20 expression blocks OxLDL-mediated cell toxicity and apoptosis. OxLDL induced the expression of Fas and FasL, and the subsequent caspase-8 cleavage and treatment with a neutralizing ZB4 anti-Fas antibody blocked apoptosis induced by OxLDL. Expression of dominant negative FADD efficiently prevented OxLDL-induced apoptosis and caspase-8 activation. A20 expression significantly attenuated the increased expression of Fas and FasL, and Fas-mediated apoptosis. These findings suggest that A20-mediated protection from OxLDL may occur at the level of Fas/FADD-caspase-8 and be FasL dependent. Treatment of RAW264.7 cells with OxLDL induces a series of time-dependent events, including the release of cytochrome c, Smac and Omi from the mitochondria to the cytosol, activation of caspase-9, -6, -2, and -3, which are blocked by A20 expression. No cleaved form of Bid was detected, even treatment with OxLDL for 48 h. Expression of dominant negative FADD also efficiently prevented OxLDL-induced the above apoptotic events. The release of cyto c, Smac and Omi from mitochondria to cytosol, activated by OxLDL treatment, and the activation of caspase-9 may not be a downstream event of caspase-8-mediated Bid cleavage. Therefore, the protective effect of A20 on mitochondrial apoptotic pathway activated by OxLDL may be dependent on FADD. A20 expression reversed OxLDL-mediated G(0)/G(1) stage arrest by maintaining the expression of cyclin B1, cyclin D1, and cyclin E, and p21 and p73. Thus, A20 expression blocks OxLDL-mediated apoptosis in murine RAW264.7 macrophages through disrupting Fas/FasL-dependent activation of caspase-8 and the mitochondria pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16646083     DOI: 10.1002/jcp.20665

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  17 in total

1.  Assessing mitochondrial redox status by flow cytometric methods: vascular response to fluid shear stress.

Authors:  Rongsong Li; Nelson Jen; Fei Yu; Tzung K Hsiai
Journal:  Curr Protoc Cytom       Date:  2011-10

2.  Tumor suppressor A20 protects against cardiac hypertrophy and fibrosis by blocking transforming growth factor-beta-activated kinase 1-dependent signaling.

Authors:  He Huang; Qi-Zhu Tang; Ai-Bing Wang; Manyin Chen; Ling Yan; Chen Liu; Hong Jiang; Qinglin Yang; Zhou-Yan Bian; Xue Bai; Li-Hua Zhu; Lang Wang; Hongliang Li
Journal:  Hypertension       Date:  2010-06-28       Impact factor: 10.190

3.  Novel anti-apoptotic mechanism of A20 through targeting ASK1 to suppress TNF-induced JNK activation.

Authors:  M Won; K A Park; H S Byun; K-C Sohn; Y-R Kim; J Jeon; J H Hong; J Park; J H Seok; J M Kim; W-H Yoon; I-S Jang; H M Shen; Z G Liu; G M Hur
Journal:  Cell Death Differ       Date:  2010-05-07       Impact factor: 15.828

Review 4.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

5.  miR-155 inhibits oxidized low-density lipoprotein-induced apoptosis of RAW264.7 cells.

Authors:  Guo-fu Zhu; Li-xia Yang; Rui-wei Guo; Hong Liu; Yan-kun Shi; Hong Wang; Jin-shan Ye; Zhi-hua Yang; Xing Liang
Journal:  Mol Cell Biochem       Date:  2013-10       Impact factor: 3.396

6.  Association of Increased F4/80high Macrophages With Suppression of Serum-Transfer Arthritis in Mice With Reduced FLIP in Myeloid Cells.

Authors:  Qi-Quan Huang; Robert Birkett; Renee E Doyle; G Kenneth Haines; Harris Perlman; Bo Shi; Philip Homan; Lianping Xing; Richard M Pope
Journal:  Arthritis Rheumatol       Date:  2017-08-01       Impact factor: 10.995

7.  Genome-wide transcriptional response of primary alveolar macrophages following infection with porcine reproductive and respiratory syndrome virus.

Authors:  Sem Genini; Peter L Delputte; Roberto Malinverni; Maria Cecere; Alessandra Stella; Hans J Nauwynck; Elisabetta Giuffra
Journal:  J Gen Virol       Date:  2008-10       Impact factor: 3.891

8.  Bcl10 is an essential regulator for A20 gene expression.

Authors:  Wu Xu; Liquan Xue; Yi Sun; Aline Henry; Jennifer M Battle; Mathieu Micault; Stephan W Morris
Journal:  J Physiol Biochem       Date:  2013-05-16       Impact factor: 4.158

9.  Cancer stem cell-specific scavenger receptor CD36 drives glioblastoma progression.

Authors:  James S Hale; Balint Otvos; Maksim Sinyuk; Alvaro G Alvarado; Masahiro Hitomi; Kevin Stoltz; Qiulian Wu; William Flavahan; Bruce Levison; Mette L Johansen; David Schmitt; Janna M Neltner; Ping Huang; Bin Ren; Andrew E Sloan; Roy L Silverstein; Candece L Gladson; Joseph A DiDonato; J Mark Brown; Thomas McIntyre; Stanley L Hazen; Craig Horbinski; Jeremy N Rich; Justin D Lathia
Journal:  Stem Cells       Date:  2014-07       Impact factor: 6.277

10.  Modulation of angiogenic and inflammatory response in glioblastoma by hypoxia.

Authors:  Anastasia Murat; Eugenia Migliavacca; S Farzana Hussain; Amy B Heimberger; Isabelle Desbaillets; Marie-France Hamou; Curzio Rüegg; Roger Stupp; Mauro Delorenzi; Monika E Hegi
Journal:  PLoS One       Date:  2009-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.